A legislative reform being prepared by the European Union plans to promote the use of already approved drugs to treat other illnesses. Doing so will speed up the approval of treatments and save on research costs
Concerns about the prices of medicines have grown over recent years. British legislators will this year renegotiate the terms of the pricing and access scheme for branded medicines between the Government and the pharmaceutical industry, seeking to control growth in prices.
Note From the Editors With 2022 well underway, the rapid pace of statutory, regulatory, policy, and industry activities in digital health continues in force. We bring you Vital Signs, a.